NCT06097728 2026-03-04
eVOLVE-Meso
AstraZeneca
Phase 3 Recruiting
Clinical Trials
4 trialsNCT02899299 2024-05-21
CheckMate743
Bristol-Myers Squibb
Phase 3 Completed
NCT00128102 2020-10-26
MK-0683-014
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT00190762 2007-01-26
A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma
Eli Lilly and Company
Phase 3 Completed